Univerzitna Nemocnica Martin — Clinical Trial Site

68 Registered trials

29 Currently recruiting

Organisation

Univerzitna Nemocnica Martin

Location

Martin, Slovakia

Identifier

ORG-100041101

Address

Kollarova 2, 036 01, Slovakia

Departments

#3326: I. Interná klinika
#5506: Neurologická klinika
1.Interna klinika 1.internal medicine clinic
3261: Transplantačno-nefrologické oddelenie
3352: Transplantačné centrum
Ambulancia klinickej alergologie a imunologie
Ambulancia klinickej imunológie a alergológie
Ambulancia pediatrickej gastroenterologie, hepatologie a vyzivy
Ambulancia radiacnej onkologie
Cardiology department
Centrum pre hereditarny angioedem
Department of Hematology and Transfusiology
Dermatovenerologicka klinika
Dermatovenerology
Gynecology and Obstetrics Clinic
Interna klinika gastroenterologicka, Kollarova 2, 036 59, Martin
Internal Clinic-Gastroenterology
Kardiologicke oddelenie
KDAD
Klinika deti a dorastu
Klinika deti a dorastu, Ambulancia pediatrickej gastroenterologie, hepatologie a vyzivy
Klinika detí a dorastu, Ambulancia pediatrickej neurológie
Klinika detí a dorastu, Oddelenie pediatrickej intenzívnej medicíny
Klinika detskej anestéziológie a intenzívnej medicíny
Klinika hematológie a transfuziológie
Klinika hematologie a transfuziologie JLF UK a UNM
Klinika infektológie a cestovnej medicíny
Klinika pneumológie a ftizeológie
N/A
NA
Neonatologická klinika
Neurologicka klinika
Neurologicka klinika JLF UK a UNM
Neurologickáklinika JLF UK a UNM
Neurology
Oddelenie klinickej imunologie a alergologie
Onkologické centrum
Outpatient clinical radiotherapy care in hospital
Pneumology and Phtisiology Clinic
Pneumology department
Transplantačno - nefrologická ambulancia
Transplantacno-nefrologicke oddelenie
Transplantation and Nephrology Department
Transplantation-nephrology department
Univerzitna Nemocnica Martin
Urological Clinic
Urologicka klinika
Urologická klinika JLF UK a UNM

Clinical trials at this site (68)

Search interface

A randomized, double-blind, placebo-controlled multicenter study to evaluate the effect of inclisiran on preventing major adverse cardiovasc… Unknown

2022-502779-40-99 Primary prevention of atherosclerotic cardiovascular di 5
A Study to Learn About the Study Medicine Called Aztreonam-Avibactam in Neonates and Infants Less Than 9 Months of Age With Suspected or Con… Pending

2023-507757-15-01 Blood Stream Infection 4
A Phase 3 Study of Orelabrutinib in Patients with Primary Progressive Multiple Sclerosis Recruiting

2025-524316-11-00 Primary Progressive Multiple Sclerosis (PPMS) 5 2026-06-11
PODOMOUNT-Basket, a study to test whether BI 764198 helps adults and adolescents with different types of kidney disease Recruiting

2025-523425-17-00 Proteinuric kidney diseases 4 2026-06-03
A Study of how the Medicine Called "Etrasimod" Works in Children With the gut Disease Called Ulcerative Colitis Recruiting

2025-523100-77-00 Ulcerative Colitis 4 2026-04-23
A study to find out if BI 764198 helps adults and adolescents with a kidney condition called focal segmental glomerulosclerosis (FSGS) Recruiting

2025-522191-86-00 Focal segmental glomerulosclerosis 5 2026-04-02
A study to assess the efficacy and safety of empasiprubart in adults with CIDP Recruiting

2025-520805-10-00 Chronic inflammatory demyelinating polyneuropathy (CIDP 5 2026-03-12
A study to assess efficacy and safety of empasiprubart versus IVIg in adults with CIDP ("emvigorate") Recruiting

2024-520097-36-00 Chronic inflammatory demyelinating polyneuropathy (CIDP 5 2026-01-07
Phase 3 Study of T-DXd and Rilvegostomig versus Standard of Care in Advanced HER2-expressing Biliary Tract Cancer Recruiting

2023-508057-19-00 Advanced HER2-expressing Biliary Tract Cancer 5 2025-09-23
The AIRTIVITY TM Study: A study to find out whether BI 1291583 helps people with bronchiectasis Recruiting

2024-518589-29-00 Bronchiectasis 5 2025-08-21
Long-term Safety and Tolerability of TAK-881 in Subjects with Primary Immunodeficiency Diseases (PIDD) Recruiting

2023-505946-24-00 Primary Immunodeficiency Diseases 5 2025-05-15
Efficacy and safety study of frexalimab (SAR441344) in adults with relapsing forms of multiple sclerosis Recruiting

2023-504358-36-00 multiple sclerosis 5 2024-10-17
Double-blind, Randomized, Placebo-controlled Study Evaluating the Safety and Efficacy of Nipocalimab in Reducing the Risk of Fetal and Neona… Recruiting

2023-504307-88-00 Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT) 5 2024-02-20
This study is to find out the safety and effectiveness of Epcoritamab together with R-CHOP (rituximab, cyclophosphamide, doxorubicin HCL, vi… Recruiting

2023-505277-32-00 Diffuse Large B-Cell Lymphoma (DLBCL) 5 2023-01-26
Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen (TILIA). Recruiting

2023-507031-38-00 Severe viral lung infections 5 2023-01-09
An extension phase 2/3 study to test the safety of long term administration of oral PHA-022121 for acute treatment of angioedema attacks in … Recruiting

2023-505766-28-00 Hereditary angioedema 10 2022-10-10
A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Parti… Recruiting

2024-517991-39-00 Asthma 5 2025-07-22
A phase III, randomized, open-label, blinded endpoint, comparative trial of ferric derisomaltose versus no intravenous iron in iron-deficien… Recruiting

2024-519059-28-00 Chronic Heart Failure 5 2025-07-17
CHAPTER-4 – A long term trial of deucrictibant treatment in prophylaxis against HAE attacks in adults and adolescents Recruiting

2024-516248-24-00 Hereditary Angioedema 5 2025-03-28
C2321003: A Study to Learn About the Investigational Medicine Called PF-06821497 (Mevrometostat) in Men with Metastatic Castration-Resistant… Recruiting

2024-511652-40-00 METASTATIC CASTRATION RESISTANT PROSTATE CANCER 5 2025-02-05
A study to evaluate the efficacy and safety of frexalimab, brivekimig or rilzabrutinib in participants aged 16 to 75 years with primary foca… Recruiting

2024-511775-15-00 Immune system diseases 4 2025-01-17
This is a study to evaluate safety and efficacy of Upadacitinib comparing to Dupilumab in children from 2 to less than 12 years of age with … Recruiting

2023-504713-76-00 Dermatitis atopic 5 2024-12-03
202301CPC Redefine-HF Recruiting

2023-508581-15-00 Heart condition 5 2024-10-08
Long-term clinical trial of PQ Grass in paediatric subjects with seasonal allergic rhinitis and/or rhinoconjunctivitis induced by grass poll… Recruiting

2023-508520-36-00 Seasonal allergic rhinitis/rhinoconjunctivitis induced 5 2024-09-06